Wei Lin's Insider Trades & SAST Disclosures
Wei Lin's most recent trade in Revolution Medicines Inc was a trade of 72,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Wei Lin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Wei Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 72,800 | 72,800 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Wei Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 20,800 | 91,651 (0%) | 0% | 0 | Common Stock | |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 16,483 | 236,616 (1%) | 0% | 0 | Common Stock, $.001 par value | |
| Revolution Medicines Inc | Wei Lin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 17 Jun 2024 | 5,589 | 70,851 (0%) | 0% | 37.4 | 208,954 | Common Stock |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 24,100 | 24,100 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,050 | 32,850 | - | 0 | Common Stock | |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Purchase of securities on an exchange or from another person at price $ 12.70 per share. | 18 Mar 2024 | 31,370 | 220,133 (1%) | 0% | 12.7 | 398,283 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 40,925 | 188,763 (0%) | 0% | 0 | Common Stock, $.001 par value | |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,450 | 8,450 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 4,200 | 20,800 | - | 0 | Common Stock | |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 33,400 | 33,400 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 16,600 | 16,600 | - | 0 | Common Stock | |
| Erasca Inc | Wei Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 560,000 | 560,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Wei Lin | Chief Medical Officer | Other type of transaction at price $ 4.10 per share. | 01 Feb 2023 | 1,748 | 315,812 | - | 4.1 | 7,162 | Common Stock |
| Erasca Inc | Wei Lin | Chief Medical Officer | Other type of transaction at price $ 4.00 per share. | 01 Feb 2023 | 2 | 315,812 | - | 4 | 8 | Common Stock |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 06 Sep 2022 | 4,438 | 147,838 (0%) | 0% | 2.2 | 9,941 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 52,995 | 152,276 (0%) | 0% | 0 | Common Stock, $.001 par value | |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. | 06 Jun 2022 | 1,224 | 99,281 (0%) | 0% | 2.3 | 2,766 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.55 per share. | 04 Mar 2022 | 1,214 | 100,505 (0%) | 0% | 3.6 | 4,310 | Common Stock, $.001 par value |
| Erasca Inc | Wei Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 272,100 | 272,100 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | Wei Lin | Chief Medical Officer | Other type of transaction at price $ 11.60 per share. | 01 Feb 2022 | 1,562 | 314,062 | - | 11.6 | 18,123 | Common Stock |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.38 per share. | 06 Dec 2021 | 1,210 | 101,719 (0%) | 0% | 5.4 | 6,510 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 07 Sep 2021 | 1,207 | 102,929 (0%) | 0% | 7.7 | 9,294 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 07 Jun 2021 | 1,083 | 89,598 (0%) | 0% | 8.4 | 9,119 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.96 per share. | 05 Mar 2021 | 1,083 | 90,681 (0%) | 0% | 8.0 | 8,621 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Purchase of securities on an exchange or from another person at price $ 7.82 per share. | 11 Dec 2020 | 25,401 | 91,764 (0%) | 0% | 7.8 | 198,725 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 07 Dec 2020 | 1,083 | 66,363 (0%) | 0% | 8.4 | 9,141 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.17 per share. | 08 Sep 2020 | 1,082 | 67,446 (0%) | 0% | 10.2 | 11,004 | Common Stock, $.001 par value |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 13,053 | 68,528 (0%) | 0% | 0 | Common Stock, $.001 par value | |
| Applied Optoelectronics Inc | Che-Wei Lin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.82 per share. | 01 Jun 2020 | 1,063 | 55,475 (0%) | 0% | 8.8 | 9,376 | Common Stock, $.001 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges